查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402577

第三代定序仪市场：依技术类型、按组件、按应用、按最终用户、按地区

Third Generation Sequencing Market, By Type of Technology, By Component, By Application:, By End-User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年全球第三代定序市值为6.080亿美元，预计2030年将达22.973亿美元，2023年至2030年复合年增长率为21.1%。

报告范围 报告详情
基准年 2022年 2023年市场规模 6.008 亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 21.10% 2030年市场规模预测 22.973 亿美元
图 1. 2023 年第三代定序仪的全球市场占有率(%)（按地区）
第三代定序市场-IMG1

第三代定序（也称为长读长定序）是一类DNA定序方法。第三代定序仪透过在单分子层级上读取序列来工作，并且可以产生比目前方法长得多的读取。它能够产生比第二代定序仪（也称为次世代定序仪）更长的读取。此外，第三代定序正成为 cDNA定序的「黄金标准」技术。

市场动态：

慢性病和感染疾病的传播、临床诊断应用的增加、基因组学应用的扩大、对药物研发和市场开拓的更多关注、与传统技术相比效率的提高等因素正在推动对第三代测序仪的需求。这些是预计推动市场成长的主要因素。

例如，随着慢性病负担的日益加重，基于第三代定序技术的设备的使用和需求也在迅速增长。 TGS技术可用于研究慢性病的基因表现，有助于了解慢性病的分子机制。根据世界卫生组织（WHO）2023年9月的报告，非传染性疾病（NCD）每年导致4,100万人死亡，占全球死亡人数的74%。大多数非传染性疾病死亡是由心血管疾病引起的，每年死亡人数为 1,790 万人，其次是癌症（930 万人）、慢性呼吸道疾病（410 万人）和糖尿病（200 万人）。

此外，根据美国疾病管制与预防中心 (CDC) 的数据，心臟病、癌症和糖尿病等慢性疾病是美国死亡和残疾的主要原因。

本研究的主要特点

  • 本报告对全球第三代定序仪市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030年）的市场规模和年复合成长率（CAGR%）。
  • 它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据以下参数（例如公司亮点、产品系列、主要亮点、财务实绩和策略）介绍了全球第三代定序市场的主要企业。
  • 该报告的见解将使行销人员和经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略负责人资讯的决策。
  • 全球第三代定序仪市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球第三代定序市场的各种策略矩阵来促进他们的决策。

目录：

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 精准医疗需求不断成长
    • 高成本和技术挑战
    • TGS 平台的采用率提高
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第 4 章 第三代定序市场 -冠状病毒(COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第 5 章 第三代定序仪市场，依技术划分，2023-2030 年

  • 单分子即时 (SMRT) 定序
  • 奈米孔定序
  • 合成长读定序

第 6 章 第三代定序仪市场，依组成部分，2020-2030 年

  • 产品
  • 工具
  • 试剂及消耗品
  • 服务

第 7 章 2023-2030 年第三代定序仪市场（依应用）

  • 基因组序列测定
  • 磊晶
  • 转录组学
  • 宏基因体学
  • 其他的

第 8 章 第三代定序仪市场，依最终使用者划分，2023-2030 年

  • 生物製药公司
  • 医院和诊所
  • 合约研究组织（CRO）
  • 其他的

第 9 章 2018-2030 年第三代定序仪市场（按地区）

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争形势

  • PacBio
  • Oxford Nanopore Technologies, Ltd.
  • BGI Genomics Co., Ltd.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN NV
  • Agilent Technologies, Inc.
  • GenapSys Inc.
  • Loop Genomics
  • Nabsys, Inc.
  • Genia Technologies, Inc.
  • Stratos Genomics, Inc.
  • GATC Biotech AG
  • Phase Genomics, Inc.

第11章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5721

The global Third Generation Sequencing market was valued at US$ 600.8 Mn in 2023 and is forecast to reach a value of US$ 2,297.3 Mn by 2030 at a CAGR of 21.1% between 2023 and 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 600.8 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 21.10% 2030 Value Projection: US$ 2,297.3 Mn
Figure 1. Global Third Generation Sequencing Market Share (%), by Region, 2023
Third Generation Sequencing Market - IMG1

Third-generation sequencing (also known as long-read sequencing) is a class of DNA sequencing methods. Third-generation sequencing works by reading nucleotide sequences at a single molecule level, which is capable of producing substantially much longer reads than the current methods. It has the ability to generate longer reads than second-generation sequencing, also known as next-generation sequencing. Moreover, third-generation sequencing has emerged as the 'gold-standard' technology for cDNA sequencing.

Market Dynamics:

Rising prevalence of chronic and infectious diseases, increasing applications in clinical diagnosis, growing applications of genomics, rise in focus on drug discovery and development, and growing efficiency compared to traditional technologies are major factors expected to propel growth of the global third generation sequencing market.

For instance, with the rise in burden of chronic disease, the usage or demand for third-generation sequencing technology-based devices is also increasing with a rapid pace. TGS technologies can be utilized in studying gene expression of chronic diseases as it help in understanding their molecular mechanisms. According to the World Health Organization (WHO), September 2023 report, non-communicable diseases (NCDs) kill 41 million individuals each year, equivalent to 74% of all deaths worldwide. Cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million).

Moreover, according to the Centers for Disease Control and Prevention (CDC), chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the U.S.

Key features of the study:

  • This report provides in-depth analysis of the global third generation sequencing market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global third generation sequencing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include PacBio , Oxford Nanopore Technologies, Ltd., BGI Genomics Co., Ltd., F. Hoffmann-La Roche AG, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Agilent Technologies, Inc., GenapSys Inc., Loop Genomics, Nabsys, Inc., Genia Technologies, Inc., Stratos Genomics, Inc., GATC Biotech AG, and Phase Genomics, Inc., among others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global third generation sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global third generation sequencing market.

Detailed Segmentation:

  • By Technology:
    • Single-Molecule Real-Time (SMRT) Sequencing
    • Nanopore Sequencing
    • Synthetic long-read sequencing
  • By Component:
    • Products
    • Instruments
    • Reagents and consumables
    • Services
  • By Application:
    • Genome Sequencing
    • Epigenetics
    • Transcriptomics
    • Metagenomics
    • Others
  • By End-user:
    • Biopharmaceutical companies
    • Hospitals and clinics
    • Contract research organizations (CROs)
    • Others (Academic and research institutes)
  • By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles:
    • PacBio
    • Oxford Nanopore Technologies, Ltd.
    • BGI Genomics Co., Ltd.
    • F.Hoffmann-La Roche AG
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • QIAGEN N.V.
    • Agilent Technologies, Inc.
    • GenapSys Inc.
    • Loop Genomics
    • Nabsys, Inc.
    • Genia Technologies, Inc.
    • Stratos Genomics, Inc.
    • GATC Biotech AG
    • Phase Genomics, Inc.

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Third Generation Sequencing, By Technology
    • Market Third Generation Sequencing, By Component
    • Market Third Generation Sequencing, By Application
    • Market Third Generation Sequencing, By End User
    • Market Third Generation Sequencing, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing Demand for Precision Medicine
    • High Cost & Technical Challenges
    • Increasing Adoption of TGS Platforms
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Third Generation Sequencing Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Third Generation Sequencing Market, By Technology, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2023 - 2030
    • Segment Trends
  • Single-molecule real-time (SMRT) sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Nanopore Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Synthetic long-read sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Third Generation Sequencing Market, By Component, 2020-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2023 - 2030
    • Segment Trends
  • Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Instruments
  • Reagents and consumables
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Third Generation Sequencing Market, By Application, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Genome Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Epigenetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Transcriptomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Metagenomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

8. Third Generation Sequencing Market, By End User, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Contract research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

9. Third Generation Sequencing Market, By Geography, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2019 - 2030, (US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2019 - 2030, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2019 - 2030, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2019 - 2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2019 - 2030, (US$ Mn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2019 - 2030, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • PacBio
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Oxford Nanopore Technologies, Ltd.
  • BGI Genomics Co., Ltd.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • GenapSys Inc.
  • Loop Genomics
  • Nabsys, Inc.
  • Genia Technologies, Inc.
  • Stratos Genomics, Inc.
  • GATC Biotech AG
  • Phase Genomics, Inc.
  • Analyst Views

11. Section

  • Research Methodology
  • About us